Dixon Technologies reported a 33% increase in revenue to ₹15,351 crore for Q2 2025 (July-September). EBIDTA surged by 152% to ₹1,057 crore, and PAT grew by 81% to ₹746 crore. The board also approved granting 7,000 employee stock options under the ‘DIXON ESOP 2023’ plan, as revealed in the meeting held on October 17, 2025.
Strong Financial Performance
Dixon Technologies announced impressive consolidated financial results for Q2 2025. Key highlights include:
- Revenue from Operations: Increased by 33% to ₹15,351 crore compared to the same quarter last year.
- EBIDTA: Rose significantly by 152% to ₹1,057 crore.
- Profit Before Tax (PBT): Experienced a substantial increase of 75%, reaching ₹924 crore.
- Profit After Tax (PAT): Grew by 81% to ₹746 crore.
The half-year results ending September 30, 2025, also demonstrated strong growth.
- Revenue from Operations: Up 56% to ₹28,188 crore.
- EBIDTA: Increased by 128% to ₹1,541 crore.
- PBT: Rose by 82% to ₹1,289 crore.
- PAT: Grew by 86% to ₹1,026 crore.
Employee Stock Option Plan
Dixon Technologies also announced the approval of a grant of 7,000 stock options to its employees and those of its subsidiaries and joint ventures. These options are convertible into an equal number of equity shares under the Dixon Technologies (India) Limited- Employee Stock Option Plan- 2023 (“DIXON ESOP 2023”). The Nomination and Remuneration Committee approved this grant during its meeting on October 17, 2025.
Details of the ESOP Grant
- Total Options Granted: 7,000
- Vesting Period: Three years from the date of grant.
- Exercise Period: One year from the date of last vesting.
- Exercise Price: Based on the market price (latest closing price) on a recognized stock exchange, with a potential discount of up to 15%.
Source: BSE
